Neuroleptic malignant syndrome (NMS) is a rare neurological condition associated with the use of antipsychotic medications. Autonomic dysfunction, or damage to the nerves that control involuntary ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
NMS Capital has appointed Duffy to its operating executive council. In this role, Duffy will work to identify, partner with, and build industry leading businesses within the outsourced pharmaceutical ...
A lot of the microstructure debate centers around “Reg NMS.” But what is Reg NMS? And what are those rule numbers people quote? Well, Reg stands for Regulation and NMS stands for National Market ...
NEW YORK and STRASBOURG, France, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today that it has expanded ...
(FLASH FRIDAY is a weekly content series looking at the past, present and future of capital markets trading and technology. FLASH FRIDAY is sponsored by Instinet, a Nomura company.) Is the Reg NMS ...
Neuroleptic malignant syndrome (NMS) is a rare reaction to antipsychotic drugs that are used to treat schizophrenia, bipolar disorder, and other mental health conditions. It affects the nervous system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results